Article
The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
British journal of haematology - 1 Sept 2015
Olsson Linda, Ivanov Öfverholm Ingegerd, Norén-Nyström Ulrika, Zachariadis Vasilios, Nordlund Jessica, Sjögren Helene, Golovleva Irina, Nordgren Ann, Paulsson Kajsa, Heyman Mats, Barbany Gisela, Johansson Bertil
Abstract excerpt
Paediatric B-cell precursor acute lymphoblastic leukaemias (BCP ALL) with IKZF1 deletions (∆IKZF1) are associated with a poor outcome. However, there are conflicting data as to whether ∆IKZF1 is an independent risk factor if minimal residual disease (MRD) and other copy number alterations also are taken into account. We investigated 334 paediatric BCP ALL, diagnosed 1992-2013 and treated according to Nordic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.